Portland, OR, United States of America

Meredith Hartley

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Oregon Health & Science University, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meredith Hartley. Retrieved from https://idiyas.com/inventor/meredith-hartley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Meredith Hartley: Innovator in Neurodegenerative Disease Treatment

Introduction

Meredith Hartley is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of neurodegenerative diseases, particularly through her innovative research and patented methods.

Latest Patents

Hartley's latest patents focus on the use of sobetirome in the treatment of myelination diseases. These patents describe methods for treating subjects who are at risk of developing neurodegenerative diseases or conditions associated with demyelination, insufficient myelination, or underdevelopment of the myelin sheath. The methods include the administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.

Career Highlights

Throughout her career, Meredith Hartley has worked with esteemed organizations such as Oregon Health & Science University and the United States Government as represented by the Department of Veterans Affairs. Her work has been instrumental in advancing the understanding and treatment of neurodegenerative conditions.

Collaborations

Some of her notable coworkers include Thomas S. Scanlan and Andrew Placzek, who have collaborated with her on various research projects.

Conclusion

Meredith Hartley is a trailblazer in the field of neurodegenerative disease treatment, with a focus on innovative methods that utilize sobetirome. Her contributions continue to impact the medical community and improve the lives of those affected by these conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…